Debut Biotechnology has a total of 67 patents globally, out of which 3 have been granted. Of these 67 patents, more than 82% patents are active. The United States of America is where Debut Biotechnology has filed the maximum number of patents, followed by Europe (EPO). Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Debut Biotechnology.
Debut Biotechnology was founded in 2019. Debut Biotechnology is a company that uses science and new ideas to create eco-friendly beauty products. It combines biotechnology with creative thinking to build modern beauty brands. Their goal is to make beauty more sustainable and better for the planet.
Do read about some of the most popular patents of Debut Biotechnology which have been covered by us in this article and also you can find Debut Biotechnology patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Debut Biotechnology patent portfolio.
How many patents does Debut Biotechnology have?
Debut Biotechnology has a total of 67 patents globally. These patents belong to 20 unique patent families. Out of 67 patents, 55 patents are active.
How Many Patents did Debut Biotechnology File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Debut Biotechnology Applications Filed | Debut Biotechnology Patents Granted |
| 2025 | 1 | 1 |
| 2024 | 14 | 2 |
| 2023 | 14 | – |
| 2022 | 28 | – |
| 2021 | 10 | – |
How many Debut Biotechnology patents are Alive/Dead?
Worldwide Patents
How Many Patents did Debut Biotechnology File in Different Countries?
Countries in which Debut Biotechnology Filed Patents
| Country | Patents |
| United States of America | 14 |
| Europe (EPO) | 6 |
| Canada | 5 |
| Japan | 5 |
| China | 4 |
| Australia | 4 |
| Singapore | 3 |
| India | 2 |
| Israel | 2 |
| Brazil | 1 |
Where are Research Centers of Debut Biotechnology Patents Located?
The Research Centers of DebutBiotechnology Patents is the United States of America.
Best Debut Biotechnology Patents
US20220193655A1 is the most popular patent in the Debut Biotechnology portfolio. It has received 2 citations so far from companies.
Below is the list of the most cited patents of Debut Biotechnology:
| Publication Number | Citation Count |
| US20220193655A1 | 2 |
| US12006528B2 | 1 |
| US11905544B2 | 1 |
| EP4319742A1 | 1 |
| US20220333087A1 | 1 |
| WO2022216720A1 | 1 |
What Percentage of Debut Biotechnology US Patent Applications were Granted?
Debut Biotechnology (Excluding its subsidiaries) has filed 11 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 2 have been granted leading to a grant rate of 100%.
Below are the key stats of Debut Biotechnology patent prosecution at the USPTO.
Which Law Firms are managing US Patents for Debut Biotechnology?
| Law Firm | Total Applications | Success Rate |
| Brown Rudnick Llp | 11 | 100.00% |
What are Debut Biotechnology key innovation segments?
What Technologies are Covered by Debut Biotechnology?
The chart below distributes patents filed by Debut Biotechnology in different countries on the basis of the technology protected in patents. It also represents the markets where Debut Biotechnology thinks it’s important to protect particular technological inventions.
R&D Focus: How has Debut Biotechnology search focus changed over the years?
EXCLUSIVE INSIGHTS COMING SOON!
Interested in knowing about the areas of innovation that are being protected by Debut Biotechnology?
